entertainment -WSS

entertainment

author：knowledge 2025-09-28 02:31:41 - browse：3745

Layoff concept illustration of empty desks and people walking away. — Adobe

Dewpoint Therapeutics, the buzziest startup trying to tackle a new field of biology called biomolecular condensates, laid off 15% of its staff on Tuesday and acknowledged that a pair of collaboration deals with pharma companies had fallen apart.

The downsizing is temporary, CEO Ameet Nathwani told STAT. The company needed to hire new employees with expertise to help move the company’s first drugs into clinical trials and expand its AI capabilities. And with funding for early-stage biotechs still sparse, leadership opted to cut some positions and use the savings to fill new ones over the coming months. Roughly 20 positions were cut.

“We talked to investors right now [about raising more money], and they think that the environment for a preclinical company — it’s not even worth having that discussion,” Nathwani said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： How to protect coverage of PrEP

knowledge

WSS

PrEP can help anyone prevent HIV. Why do so few people take it?

Why getting cancer drugs just got harder for rural patients

How a key Senate committee is planning to regulate PBMs

The response to Covid

FDA approves first blood sugar monitor without finger pricks

Thousands protest mob assault of women who were paraded naked in remote Indian border state

hotspot

entertainment

entertainment

The cancer drug shortage isn’t new — and neither are the solutions

How a key Senate committee is planning to regulate PBMs

Hepatitis C has a cure — but many Americans still lack access to it

RSV vaccines may be linked to small increased risk of developing GBS

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

New air purifier tech could be key to improving indoor air quality

What Henrietta Lacks's story taught me about my role as a doctor

Peter Hotez and the public health issue of online harassment

AstraZeneca loses challenge to Medicare drug price negotiation

Wikipedia

Severe heat forecast: Where scorching temperatures will persist over the next week

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Statins reduce cardiovascular risk in people living with HIV

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Inside the culture of fear in the White House science office of Eric Lander

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

hotspot

knowledge

focus

hotspot